Burlington Medical Kilt Recall Over Attenuation Degradation
Areazine synthesizes this FDA recall directly from FDA's official public data feed. See our methodology for full source attribution and refresh cadence.
Burlington Medical, LLC is recalling 15,216 units of their medical kilts due to potential attenuation degradation that could reduce lifespan, affecting products manufactured from January 16, 2025, to January 21, 2026.
What this FDA recall tells you, and what most readers miss
This notice was issued by FDA on April 16, 2026 and geographically references United States. Its severity classification of "medium" signals how the issuing agency weighs the risk of harm if no action is taken - "critical" and "high" tier alerts typically carry direct consumer actions, while "medium" and "low" tend toward informational guidance or monitoring advisories. The category it belongs to - FDA Recalls - determines the consumer-protection framework behind it, which shapes what remedies (refunds, replacements, repairs, or the recall itself) are available to affected consumers and which agency holds statutory responsibility for enforcement.
Most readers skim a notice like this, check whether they are personally affected, and move on. The more useful lens is to verify its scope, source, and timestamp, then compare related notices without assuming that one record proves a broader trend.
Areazine pairs this record with the original agency URL so you can check the primary source before acting. Its related labels are recall, product-safety, fda, Devices.
Burlington Medical Kilt Recall
What Happened
Burlington Medical, LLC is initiating a voluntary recall of certain medical kilts due to a potential for attenuation degradation over time, which could decrease the product's lifespan. This is classified as a Class II recall.
Which Products Are Affected
The recall affects 15,216 units of Burlington Medical kilts with various model numbers, including C8K303, R8K303, R8KILT, R8S302, R8SKIRT, S8K303, S8KILT, S8S302, S8SKIRT, U8K303, U8KILT, and U8S302. All serial numbers manufactured with Xenolite 800 attenuation material from January 16, 2025, to January 21, 2026, are included. Specific UDI-DI codes are associated with these models, such as 00840331297638 for C8K303 variants. The products were distributed nationwide in the United States and internationally to countries including Canada, Australia, and others. The official recall number is Z-1755-2026.
What You Should Do
Consumers should contact Burlington Medical, LLC for further instructions, as the recall was initiated via letter. For returns or refunds, reach out to the firm at their address: 3 Elmhurst St, Suite 112, Newport News, VA 23603-1137.
Why This Matters
This recall addresses potential safety issues with medical devices, ensuring users are protected from risks associated with degraded attenuation in 1-2 sentences.
Source
Attributed to the FDA; recall details available under recall number Z-1755-2026.
Original source: FDA Official Notice ↗
Related FDA Recalls
All FDA Recalls →Nationwide notices with similar length or severity timing 8
Two Areazine-derived peer sets for this FDA recall: nearest notices by body length and by same severity near the same agency date. Peers come from other categories so they are not the same-feed Related list above.
Similar body length
Nearest notices by article body length (1,449 characters here).
Similar severity timing
Same severity (medium) notices issued closest in time to April 16, 2026.
Frequently Asked Questions
Common questions about this FDA recall.